Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 67 Breast Neoplasms, Male 4 Neoplasm Metastasis 3 Neoplasms 2 Advanced Breast Cancer 2 Unilateral Breast Neoplasms 1 Sleep Wake Disorders 1 Recurrence 1 Ovarian Neoplasms 1 Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1 First Line Metastatic Breast Cancer 1 Fatigue 1 Carcinoma, Intraductal, Noninfiltrating 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Carcinoma In Situ 1 Breast Cancer Metastatic 1 Breast Cancer Female 1 Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Tamoxifen 2 pegfilgrastim 1 exemestane 1 abemaciclib 1 Tretinoin 1 Tocopherols 1 Standard of Care 1 Mifepristone 1 Letrozole 1 Isotretinoin 1 Dexmedetomidine 1 Cannabidiol 1 Bupivacaine 1 Anastrozole 1 Alitretinoin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Cancer Female × exemestane × Clear all

NCT04584853 2026-01-14

POETIC-A

Institute of Cancer Research, United Kingdom

Phase 3 Active not recruiting

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡